Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Vaxcyte, Inc. (PCVX) had Current Assets of $1.10B for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-180.80M |
|
-- |
|
-- |
|
$196.68M |
|
$-196.68M |
|
$15.88M |
|
$-180.80M |
|
$-180.80M |
|
$-180.80M |
|
$-180.80M |
|
$-180.80M |
|
$-180.80M |
|
$-196.68M |
|
$-196.10M |
|
97.16M |
|
97.16M |
|
$-1.83 |
|
$-1.83 |
|
Balance Sheet Financials | |
Current Assets |
$1.10B |
$79.63M |
|
$311.96M |
|
$1.41B |
|
$145.34M |
|
-- |
|
$22.11M |
|
$167.45M |
|
$1.24B |
|
$1.24B |
|
$1.24B |
|
95.36M |
|
Cash Flow Statement Financials | |
$-296.79M |
|
$-773.31M |
|
$639.81M |
|
$835.53M |
|
$398.55M |
|
$-436.97M |
|
$48.76M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-312.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.58% |
|
-14.58% |
|
-12.84% |
|
-14.58% |
|
$13.01 |
|
$-3.22 |
|
$-3.05 |